Deutsch Español Français Italiano Português Pусский العربية 日本語 한국의 中文
>>Product>>Doxorubicin Hydrochloride
No.:
13
English_Name:
Doxorubicin Hydrochloride
English_Synonyms:
(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
CAS No:
25316-40-9
Formula:
C27H29NO11.HCl
Molecular_Weight:
579.99
Molecular_Structure:
北京靖源医药产品图片
Appearance:
Orange red powder
Standard:
USP31
Assay:
≥99%
Package:
Aluminm foil bag
Use:
Anti-mitotic and cytotoxic drugs. Doxorubicin can be successfully induced to alleviate a variety of malignancies, including acute leukemia, lymphoma, soft tissue and osteosarcoma, malignant tumors of children and adult solid tumors, especially for breast and lung cancer.

Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.

This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Section 68B of the Patents Act of 1953 in New Zealand; (vi) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (vii) such similar laws and rules as may apply in various other countries.

Not available in some countries; not available to some institutions; not available for some uses.